As concern over the safety of flu vaccines increases, a lawmaker feel a local drug company is putting profit above public safety, according to a lawmaker.
Currently, Korean drug-maker Green Cross Corp. has produced adjuvanted vaccines by an immunologic adjuvant from a Swiss pharmaceutical firm to increase production of a vaccine for Influenza A.
Adjuvants are sometimes added to vaccines t...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.